HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

4th Edition of International Heart Congress

June 22-24,2026 | Hybrid Event

June 22 -24, 2026 | Barcelona, Spain

Heart Valve Disease

Heart Valve Disease

Heart valve disease represents a diverse spectrum of conditions that pose significant challenges to cardiovascular health. While some cases of valve disease may remain asymptomatic for a long time, others can progress to severe complications, including heart failure. The management of heart valve disease often involves a collaborative effort among cardiologists, cardiac surgeons, and other healthcare professionals. Advances in medical technology have led to the development of less invasive procedures, such as transcatheter aortic valve replacement (TAVR), providing viable options for certain patients who may not be suitable candidates for traditional open-heart surgery. Ongoing research aims to enhance our understanding of the underlying mechanisms of valve disease and explore novel therapeutic approaches. Regular monitoring, early intervention, and personalized treatment plans are crucial elements in the comprehensive care of individuals with heart valve disease, emphasizing the importance of a multidisciplinary and patient-centered approach in addressing the complexities of this cardiovascular condition.

Committee Members
Speaker at International Heart Congress 2026 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2026 - Narendra Kumar

Narendra Kumar

HeartbeatsZ Academy, United Kingdom
Speaker at International Heart Congress 2026 - Miroslav Radenkovic

Miroslav Radenkovic

University of Belgrade, Serbia

Submit your abstract Today

Watsapp